Market Cap 1.52M
Revenue (ttm) 0.00
Net Income (ttm) -9.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,705,700
Avg Vol 6,835,680
Day's Range N/A - N/A
Shares Out 4.87M
Stochastic %K 2%
Beta 0.82
Analysts Strong Buy
Price Target $12.00

Company Profile

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100,...

Industry: Biotechnology
Sector: Healthcare
Phone: 754 231 1688
Address:
2200 N. Commerce Parkway, Suite 208, Weston, United States
kancunbum
kancunbum Sep. 9 at 10:54 PM
$ZVSA news from 3 days ago https://finance.yahoo.com/news/zyversa-therapeutics-highlights-lipidomic-data-115500827.html
0 · Reply
kancunbum
kancunbum Sep. 9 at 10:53 PM
$ZVSA NEWS https://www.tipranks.com/news/the-fly/zyversa-therapeutics-reports-q2-eps-46c-vs-3-31-last-year-thefly
0 · Reply
prismmarketview
prismmarketview Sep. 3 at 4:30 PM
PRISM Mid-Day Movers Shattuck Labs, Inc. ( $STTK) up +26.24% after OrbiMed invests $5.47M, boosting confidence in its immunotherapy pipeline. Biotricity Inc. ( $BTCY) up +23.31% following an announcement of its expansion into cardiac monitoring for consumer wearables with FDA-cleared tech. Other PRISM Mid-Day Movers: ZyVersa Therapeutics , Inc. ( $ZVSA) up 14.81% Aethlon Medical, Inc. ( $AEMD) down 15.21% https://prismmarketview.com/prism-mid-day-movers-share-purchases-and-wearables-innovation-drive-index-gains/
0 · Reply
Arya3t
Arya3t Aug. 31 at 12:55 AM
1 · Reply
Arya3t
Arya3t Aug. 30 at 2:38 PM
0 · Reply
ali9989
ali9989 Aug. 28 at 1:52 PM
$ZVSA any genuine update for this bs stock? We everr gonna see .50
0 · Reply
Stmkr
Stmkr Aug. 26 at 8:06 PM
$ZVSA https://investors.zyversa.com/news-releases/news-release-details/zyversa-therapeutics-supports-fda-authorized-emergency To my understanding 12w data from this patient could become available in October
0 · Reply
Stmkr
Stmkr Aug. 25 at 7:03 PM
$ZVSA Scary cash situation. Extremely low liquidity. But upcoming ph2a data could be huge... Any objective thoughts from anyone following?
1 · Reply
kancunbum
kancunbum Aug. 17 at 10:46 PM
$ZVSA news https://investors.zyversa.com/news-releases/news-release-details/zyversa-therapeutics-reports-second-quarter-2025-financial/
1 · Reply
John_D_Stockefeller
John_D_Stockefeller Aug. 12 at 3:07 PM
$ZVSA Sad day when this is my biggest % gainer.
1 · Reply
Latest News on ZVSA
No data available.
kancunbum
kancunbum Sep. 9 at 10:54 PM
$ZVSA news from 3 days ago https://finance.yahoo.com/news/zyversa-therapeutics-highlights-lipidomic-data-115500827.html
0 · Reply
kancunbum
kancunbum Sep. 9 at 10:53 PM
$ZVSA NEWS https://www.tipranks.com/news/the-fly/zyversa-therapeutics-reports-q2-eps-46c-vs-3-31-last-year-thefly
0 · Reply
prismmarketview
prismmarketview Sep. 3 at 4:30 PM
PRISM Mid-Day Movers Shattuck Labs, Inc. ( $STTK) up +26.24% after OrbiMed invests $5.47M, boosting confidence in its immunotherapy pipeline. Biotricity Inc. ( $BTCY) up +23.31% following an announcement of its expansion into cardiac monitoring for consumer wearables with FDA-cleared tech. Other PRISM Mid-Day Movers: ZyVersa Therapeutics , Inc. ( $ZVSA) up 14.81% Aethlon Medical, Inc. ( $AEMD) down 15.21% https://prismmarketview.com/prism-mid-day-movers-share-purchases-and-wearables-innovation-drive-index-gains/
0 · Reply
Arya3t
Arya3t Aug. 31 at 12:55 AM
1 · Reply
Arya3t
Arya3t Aug. 30 at 2:38 PM
0 · Reply
ali9989
ali9989 Aug. 28 at 1:52 PM
$ZVSA any genuine update for this bs stock? We everr gonna see .50
0 · Reply
Stmkr
Stmkr Aug. 26 at 8:06 PM
$ZVSA https://investors.zyversa.com/news-releases/news-release-details/zyversa-therapeutics-supports-fda-authorized-emergency To my understanding 12w data from this patient could become available in October
0 · Reply
Stmkr
Stmkr Aug. 25 at 7:03 PM
$ZVSA Scary cash situation. Extremely low liquidity. But upcoming ph2a data could be huge... Any objective thoughts from anyone following?
1 · Reply
kancunbum
kancunbum Aug. 17 at 10:46 PM
$ZVSA news https://investors.zyversa.com/news-releases/news-release-details/zyversa-therapeutics-reports-second-quarter-2025-financial/
1 · Reply
John_D_Stockefeller
John_D_Stockefeller Aug. 12 at 3:07 PM
$ZVSA Sad day when this is my biggest % gainer.
1 · Reply
Gingerbread_man
Gingerbread_man Aug. 7 at 4:37 PM
$ZVSA cant even buy this 🤔😅
0 · Reply
John_D_Stockefeller
John_D_Stockefeller Aug. 1 at 9:51 PM
$ZVSA Another offering. I expect another reverse split asap, and further downlisting into the Pinks, then, greys, then into the Biscayne Bay.
1 · Reply
Charleseatworld
Charleseatworld Aug. 1 at 10:21 AM
0 · Reply
ali9989
ali9989 Jul. 30 at 9:50 PM
$ZVSA anyone has an update on this stock? .50 cent was predicted for this week.?
0 · Reply
Honning
Honning Jul. 25 at 2:20 PM
0 · Reply
Honning
Honning Jul. 25 at 2:19 PM
$ZVSA this company will most likely be taken over by Novo Nordisk
0 · Reply
MuesLee
MuesLee Jul. 25 at 11:03 AM
$ZVSA does someone know to which price they sold the shares?
2 · Reply
MicrocapCowboy
MicrocapCowboy Jul. 24 at 5:58 PM
$APVO in case anyone is interested, $ZVSA is about a quarter or two behind APVO awaiting study results and a pipeline advancement and like APVO just took a huge hit from fund raising. It is unlikely it will fade much further and buying a position could pay off at some point in the coming months just like APVO.
0 · Reply
AceFurley
AceFurley Jul. 24 at 2:01 PM
$ZVSA Halted
2 · Reply
beastcrash
beastcrash Jul. 23 at 7:15 PM
0 · Reply
John_D_Stockefeller
John_D_Stockefeller Jul. 23 at 4:31 PM
$ZVSA Up this % and no attention being paid? Make it a meme!
1 · Reply
petoss
petoss Jul. 23 at 7:40 AM
$ZVSA 12mil in capital secured, prelimitarybresults q4/25 ... Potencional buyout on sucess https://finance.yahoo.com/news/zyversa-therapeutics-ceo-issues-mid-115500480.html
0 · Reply